Write-up explained what we thought was the best risk-reward strategy for trading REGN options ahead of the FDA's ruling on Eylea; a drug for Wet Age-Related Macular Degeneration (AMD).
FDA decision on Eylea is Imminent.
If you're not a subscriber but would like to receive future trades, please use Paypal in the right margin for a Quarter or Year through February 2013.
Cheers from the Psychology of the Call team (POTC) and the Ambassador of Truth through the 2012 U.S. Presidential Election:
Capitalist Pig Bob : /